Genomic or taxonomic subtyping, tumour mutation burden, PD‐L1 expression and alteration of DNA damage response (DDR)‐regulating genes are some examples of BMs, which have been suggested to hold predictive value in advanced urothelial carcinoma (UC) [12, 13, 14]. Here, CD274 is linked to neoplasm.